Cell Salvage Alters the Systemic Inflammatory Response After Off-Pump Coronary Artery Bypass Grafting Surgery

Annals of Thoracic Surgery

Volumn 83, Issue 2, 2007, Pages 578-585

  Allen, Stephen J ^a   McBride, William T ^b   McMurray, Terence J ^a   Phillips, Anne S ^a   Penugonda, S Prasad ^a   Campalani, Gianfranco ^a   Young, Ian S ^b   Armstrong, Marilyn A ^b  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 MICROGLOBULIN; BETA N ACETYLGALACTOSAMINIDASE; CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRAFT SALVAGE; HOMEOSTASIS; HUMAN; INTERMETHOD COMPARISON; MALE; OFF PUMP CORONARY SURGERY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZATION; RENAL PROTECTION; SURGICAL PATIENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33846401743     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2006.09.041     Document Type: Article

References (39)

1. Gormley S.M., Armstrong M.A., McMurray T.J., and McBride W.T. The effect of methylprednisolone on cytokine concentration and leukocyte adhesion molecule expression in an isolated cardiopulmonary bypass system. Cytokine 22 (2003) 149-155
2. Bedi A., McBride W.T., Armstrong M.A., Murray J.M., and Fee J.P. Xenon has no effect on cytokine balance and adhesion molecule expression within an isolated cardiopulmonary bypass system. Br J Anaesth 894 (2002) 546-550
3. Gormley S.M., McBride W.T., Armstrong M.A., et al. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass. Cytokine 17 (2002) 61-65
4. McBride W.T., Armstrong M.A., Crockard A.D., McMurray T.J., and Rea J.M. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuits. Br J Anaesth 75 (1995) 724-733
5. Wan S., LeClerc J.L., and Vincent J.L. Inflammatory response to cardiopulmonary bypass: mechanisms involved and possible therapeutic strategies. Chest 112 (1997) 676-692
6. McBride W.T., Armstrong M.A., and McBride S.J. Immunomodulation: an important concept in modern anaesthesia. Anaesthesia 51 (1996) 465-473
7. Laffey J.G., Boylan J.F., and Cheng D.C. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 97 (2002) 215-252
8. McBride W.T., Armstrong M.A., Gilliland H., and McMurray T.J. The balance of pro and anti-inflammatory cytokines in plasma and bronchoalveolar lavage (BAL) at paediatric cardiac surgery. Cytokine 8 (1996) 724-729
9. McBride W.T., Allen S., Gormley S.M., et al. Methylprednisolone favourably alters plasma and urinary cytokine homeostasis and sub-clinical renal injury at cardiac surgery. Cytokine 27 (2005) 81-89
10. Gormley S.M., McBride W.T., Armstrong M.A., et al. Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery. Anesthesiology 93 (2000) 1210-1216
11. Baker R.C., Armstrong M.A., Allen S.J., and McBride W.T. Role of the kidney in perioperative inflammatory responses. Br J Anaesth 88 (2002) 330-334
12. Westhuyzen J., McGiffin D.C., McCarthy J., and Fleming S.J. Tubular nephrotoxicity after cardiac surgery utilising cardiopulmonary bypass. Clin Chim Acta 228 (1994) 123-132
13. Westhuyzen J., Endre Z.H., Reece G., Reith D.M., Saltissi D., and Morgan T.J. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplant 18 (2003) 543-551
14. Price R.G. Measurement of N-acetyl-beta-glucosaminidase and its isoenzymes in urine methods and clinical applications. Eur J Clin Chem Clin Biochem 30 (1992) 693-705
15. Boldt J., Brenner T., Lang J., Kumle B., and Isgro F. Kidney-specific proteins in elderly patients undergoing cardiac surgery with cardiopulmonary bypass. Anesth Analg 97 (2003) 1582-1589
16. Gu Y.J., Mariani M.A., van Oeveren W., Grandjean J.G., and Boonstra P.W. Reduction of the inflammatory response in patients undergoing minimally invasive coronary artery bypass grafting. Ann Thorac Surg 65 (1998) 420-424
17. Matata B.M., Sosnowski A.W., and Galinanes M. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. Ann Thorac Surg 69 (2000) 785-791
18. Fransen E., Maessen J., Dentener M., Senden N., Geskes G., and Buurman W. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation. Chest 113 (1998) 1290-1295
19. Ascione R., Lloyd C.T., Underwood M.J., Lotto A.A., Pitsis A.A., and Angelini G.D. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 69 (2000) 1198-1204
20. Struber M., Cremer J.T., Gohrbandt B., et al. Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass. Ann Thorac Surg 68 (1999) 1330-1335
21. Czerny M., Baumer H., Kilo J., et al. Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. Eur J Cardiothorac Surg 17 (2000) 737-742
22. Ascione R., Lloyd C.T., Underwood M.J., Gomes W.J., and Angelini G.D. On-pump versus off-pump coronary revascularization: evaluation of renal function. Ann Thorac Surg 68 (1999) 493-498
23. Cleveland Jr. J.C., Shroyer A.L., Chen A.Y., Peterson E., and Grover F.L. Off-pump coronary artery bypass grafting decreases risk-adjusted mortality and morbidity. Ann Thorac Surg 72 (2001) 1282-1288
24. Mack M.J., Pfister A., Bachand D., et al. Comparison of coronary bypass surgery with and without cardiopulmonary bypass in patients with multivessel disease. J Thorac Cardiovasc Surg 127 (2004) 167-173
25. Hayashida N., Teshima H., Chihara S., et al. Does off-pump coronary artery bypass grafting really preserve renal function?. Circ J 66 (2002) 921-925
26. Tang A.T., Knott J., Nanson J., Hsu J., Haw M.P., and Ohri S.K. A prospective randomized study to evaluate the renoprotective action of beating heart coronary surgery in low risk patients. Eur J Cardiothorac Surg 22 (2002) 118-123
27. Schmidt H., Bendtzen K., and Mortensen P.E. The inflammatory cytokine response after autotransfusion of shed mediastinal blood. Acta Anaesthesiol Scand 42 (1998) 558-564
28. Svenmarker S., and Engstrom K.G. The inflammatory response to recycled pericardial suction blood and the influence of cell-saving. Scand Cardiovasc J 37 (2003) 158-164
29. Reents W., Babin-Ebell J., Misoph M.R., Schwarzkopf A., and Elert O. Influence of different autotransfusion devices on the quality of salvaged blood. Ann Thorac Surg 68 (1999) 58-62
30. Bengtsson A., Avall A., Hyllner M., and Bengtson J.P. Formation of complement split products and proinflammatory cytokines by reinfusion of shed autologous blood. Toxicol Lett 100-101 (1998) 129-133
31. Avall A., Hyllner M., Bengtson J.P., Carlsson L., and Bengtsson A. Greater increase in cytokine concentration after salvage with filtered whole blood than with washed red cells, but no difference in postoperative hemoglobin recovery. Transfusion 39 (1999) 271-276
32. Tylman M., Bengtson J.P., Avall A., Hyllner M., and Bengtsson A. Release of interleukin-10 by reinfusion of salvaged blood after knee arthroplasty. Intensive Care Med 27 (2001) 1379-1384
33. Amand T., Pincemail J., Blaffart F., Larbuisson R., Limet R., and Defraigne J.O. Levels of inflammatory markers in the blood processed by autotransfusion devices during cardiac surgery associated with cardiopulmonary bypass circuit. Perfusion 17 (2002) 117-123
34. Westerberg M., Bengtsson A., and Jeppsson A. Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response. Ann Thorac Surg 78 (2005) 54-59
35. Aldea G.S., Soltow L.O., Chandler W.L., et al. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits. J Thorac Cardiovasc Surg 123 (2002) 742-755
36. Van Zee K.J., Kohno T., Fischer E., Rock C.S., Moldawer L.L., and Lowry S.F. Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A 89 (1992) 4845-4849
37. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev 7 (1996) 231-240
38. Wei M., Kuukasjarvi P., Laurikka J., et al. Inflammatory cytokines and soluble receptors after coronary artery bypass grafting. Cytokine 15 (2001) 223-228
39. Walpoth B.H., Eggensperger N., Hauser S.P., et al. Effects of unprocessed and processed cardiopulmonary bypass blood retransfused into patients after cardiac surgery. Int J Artif Organs 22 (1999) 210-216